ANDA 202042, held by Micro Labs Ltd. Efavirenz.
As of Nov 16, 2026, ANDA 202042 (Efavirenz), held by Micro Labs Ltd, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 19, 2012 | Original application | Tentative approval |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters